Dividend cut to a token — earnings are negative, book is falling. In September 2026 the board cut the quarterly common dividend to $0.01 a share pre-split — $0.10 on the post-split share count after the 1-for-10 reverse split effective October 5, 2026 — explicitly to preserve capital, and the company is under a strategic review weighing a business combination, an asset sale, or a capital raise. Second-quarter distributable earnings before realized gains and losses were -$0.10 a share pre-split, and -$0.79 including realized losses, against a $0.05 dividend then in place; book value fell $1.35 in the quarter to $5.70 pre-split, with a $165.8 million CECL reserve equal to 11.4% of loan commitments. This is a distress warning in the strongest form the House rule allows short of a trap: no return-of-capital funding of the payout was verified, so it is graded warn, not bad, but a $0.01 pre-split dividend is a placeholder, not an income stream.
Key risk: The strategic review itself — a sale, combination, or capital raise could change what shareholders own, and the loan book behind it carries $90.7 million of real-estate-owned assets and risk-rated 5 loans with $120 million of specific reserves. Credit resolutions, not the dividend, decide what is left.
Changes if: The strategic review ends in a sale or wind-down, distributable earnings before gains stay negative, book value falls again, or the token dividend is suspended. Any of those confirms the dividend is no longer the point of holding this name.
- ✗Coverage check Second-quarter distributable earnings before realized gains and losses were -$0.10 a share pre-split, and -$0.79 including realized losses, against a $0.05 dividend — there were no recurring earnings covering the payout at all.
- ✗Book-value check Book value fell $1.35 in one quarter to $5.70 a share pre-split at June 30, 2026, including a $(3.44) per-share CECL reserve; the $165.8 million reserve is 11.4% of total loan commitments.
- !Leverage check Total leverage of 1.9× at June 30, 2026 looks contained, but it sits beside $58.5 million of unrestricted cash at quarter-end (about $35.7 million by August 3) and two real-estate-owned assets carried at $90.7 million — leverage is not the binding constraint, credit is.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.